维普期刊资源整合服务平台（V6.5）

60篇 您的检索式：作者名="Kent DM"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Are some patients likely to benefit from recombinant tissue-type plasminogen activator for acute ischemic stroke even beyond 3 hours from symptom onset显示文摘	Kent DM Ruthazer R Selker HP		Stroke0，，：	2
2	Effects of chemotherapy on survival of elderly patients with small-cell lung cancer:analysis of the SEER-medicare database显示文摘	Caprario LC Kent DM Strauss GM	2013	J Thorac Oncol2013，8，10：	1
3	Still no closure on the question of PFO closure 显示文摘	Mess6 SR Kent DM	2013	NEngl JMed2013，368，12：	1
4	Patent foramen ovale in eryptogenie stroke:incidental or pathogenic? 显示文摘	Alsheikh-Ali AA Thaler DE Kent DM	2009	Stroke2009，40，7：	1
5	Sex-based differences in response to recombinant tissue plasminogen activator in acute ischemic stroke: a pooled analysis of randomized clinical trials显示文摘	Kent DM Price LL Ringleb P	2005	Stroke2005，36，1：	1
6	Controversies in cardioembolic stroke 显示文摘	Wessler BS Kent DM	2015	Curt Treat Options Cardiovasc Med2015，17，1：	1
7	The stroke-thmmbolytic predictive instrument: a predictive instrument for intravenous thrombolysis in acute ischemic stroke显示文摘	Kent DM Selker HP Ruthazer R	2006	Stroke2006，37，12：	1
8	Unilateral breast masses in men over40:a diagnostic dilemma显示文摘	O'Hanlon DM Kent P Kerin MJ	1995	Am J Surg1995，170，：	1
9	Patent foramen ovale in eryptogenic stroke : incidental or pathogenic? 显示文摘	Alsheikh Ali AA Thaler DE Kent DM	2009	Stroke2009，40，7：	1
10	Comparative Effectiveness of Pharmacologic Interventions for Knee Osteoarthritis: A Systematic Review and Network Meta- analysis显示文摘	Bannuru RR Schmid CH Kent DM	2015	Ann Intern Med2015，162，1：	1
11	Sex based differences in response to recombinant tissue p]asminogen activator in acute isehemic stroke: a pooled analysis of randomized clinical trials 显示文摘	Kent DM Price LL Ringleb P	2005	Stroke2005，36，：	1
12	Patent foramen ovale in cryptogenic stroke : incidental or pathogenic 显示文摘	Alsheikh-Ali AA Thaler DE Kent DM	2009	Stroke2009，40，7：	1
13	Patent foramen ovale in cryptogenic stroke incidental or pathogenic显示文摘	Alsheikh-Ali AA Thaler DE Kent DM	2009	Stroke2009，40，：	1
14	Is patent foramen ovale a modifiable risk factor for stroke recurrence显示文摘	Kent DM Thaler DE	2010	Stroke2010，41，10：	1
15	Quantitative e- valuation of drug or device effects on ventricular remod- eling as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction: a meta-analytic approach 显示文摘	Kramer DG Trikalinos TA Kent DM	2010	J Am Coil Cardiol2010，56，5：	1
16	Still no closure on the question of PFO closure 显示文摘	Messe SR Kent DM	2013	N Engl J Med2013，368，12：	1
17	Improving diabetes prevention with benefit based tailored treatment: risk based reanalysis of Diabetes Prevention Program 显示文摘	Sussman JB Kent DM Nelson JP	2015	BMJ2015，350，：	1
18	Statins,lowdensity lipoprotein cholesterol,and risk of cancer显示文摘	Alsheikh-Ali AA Trikalions TA Kent DM	2008	J Am Coll Cardiol2008，52，14：	1
19	Predicting mortality in inci- dent dialysis patients: an analysis of the United Kingdom Renal Registry显示文摘	Wagner M Ansell D Kent DM	2011	Am J Kidney Dis2011，57，6：	1
20	Is patent foramen ovale a modifiable risk factor for stroke recurrence显示文摘	Kent DM Thaler DE	2010	Stroke2010，41，1：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示